A detailed history of Nuveen Asset Management, LLC transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 41,315 shares of ANIK stock, worth $709,791. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,315
Previous 100,076 58.72%
Holding current value
$709,791
Previous $2.53 Million 59.75%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$24.25 - $28.75 $1.42 Million - $1.69 Million
-58,761 Reduced 58.72%
41,315 $1.02 Million
Q2 2024

Aug 09, 2024

SELL
$24.57 - $28.47 $2.36 Million - $2.74 Million
-96,100 Reduced 48.99%
100,076 $2.53 Million
Q1 2024

May 13, 2024

SELL
$21.95 - $26.42 $1.52 Million - $1.83 Million
-69,300 Reduced 26.1%
196,176 $4.98 Million
Q4 2023

Feb 14, 2024

BUY
$18.47 - $23.3 $2.37 Million - $2.99 Million
128,369 Added 93.63%
265,476 $6.02 Million
Q3 2023

Nov 14, 2023

BUY
$16.98 - $26.1 $381,285 - $586,075
22,455 Added 19.59%
137,107 $2.55 Million
Q2 2023

Aug 14, 2023

SELL
$25.16 - $28.86 $165,049 - $189,321
-6,560 Reduced 5.41%
114,652 $2.98 Million
Q1 2023

May 15, 2023

BUY
$25.91 - $32.1 $1.33 Million - $1.65 Million
51,420 Added 73.68%
121,212 $3.48 Million
Q4 2022

Feb 14, 2023

BUY
$23.85 - $31.91 $359,634 - $481,170
15,079 Added 27.56%
69,792 $2.07 Million
Q3 2022

Nov 14, 2022

SELL
$21.74 - $24.68 $18,522 - $21,027
-852 Reduced 1.53%
54,713 $1.3 Million
Q2 2022

Aug 15, 2022

SELL
$20.4 - $25.53 $70,359 - $88,052
-3,449 Reduced 5.84%
55,565 $1.24 Million
Q1 2022

May 16, 2022

BUY
$24.7 - $36.54 $13,041 - $19,293
528 Added 0.9%
59,014 $1.59 Million
Q4 2021

Feb 14, 2022

SELL
$35.83 - $45.03 $135,616 - $170,438
-3,785 Reduced 6.08%
58,486 $2.16 Million
Q3 2021

Nov 12, 2021

SELL
$38.75 - $44.47 $1.15 Million - $1.32 Million
-29,680 Reduced 32.28%
62,271 $2.47 Million
Q2 2021

Aug 16, 2021

BUY
$39.42 - $48.08 $1.07 Million - $1.31 Million
27,254 Added 42.13%
91,951 $3.98 Million
Q1 2021

May 17, 2021

SELL
$32.49 - $45.96 $29,728 - $42,053
-915 Reduced 1.39%
64,697 $2.64 Million
Q4 2020

Feb 16, 2021

SELL
$32.59 - $45.26 $60,747 - $84,364
-1,864 Reduced 2.76%
65,612 $2.97 Million
Q3 2020

Nov 16, 2020

BUY
$32.56 - $38.57 $155,018 - $183,631
4,761 Added 7.59%
67,476 $2.39 Million
Q2 2020

Aug 14, 2020

BUY
$27.83 - $37.73 $257,900 - $349,643
9,267 Added 17.34%
62,715 $2.37 Million
Q1 2020

May 14, 2020

SELL
$22.38 - $54.06 $2.18 Million - $5.26 Million
-97,303 Reduced 64.55%
53,448 $1.55 Million
Q4 2019

Feb 14, 2020

SELL
$51.85 - $73.36 $3.16 Million - $4.47 Million
-60,919 Reduced 28.78%
150,751 $7.82 Million
Q3 2019

Nov 14, 2019

BUY
$40.05 - $57.47 $6.22 Million - $8.93 Million
155,339 Added 275.76%
211,670 $11.6 Million
Q2 2019

Aug 15, 2019

BUY
$30.3 - $41.14 $1.71 Million - $2.32 Million
56,331 New
56,331 $2.29 Million

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $251M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.